RANI (Rani Therapeutics Holdings, Inc. Class A Common Stock) Stock Analysis - Hedge Fund Holdings
Rani Therapeutics Holdings, Inc. Class A Common Stock (RANI) is a publicly traded Healthcare sector company. As of May 21, 2026, RANI trades at $1.09 with a market cap of $97.14M and a P/E ratio of -3.78. RANI moved +23.81% today. Year to date, RANI is -19.85%; over the trailing twelve months it is +45.51%. Its 52-week range spans $0.39 to $3.87. Analyst consensus is strong buy with an average price target of $7.00. Rallies surfaces RANI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns RANI stock?
Hedge funds tracked by Rallies that own RANI include Farallon Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Rani Therapeutics Holdings, Inc. Class A Common Stock.
RANI Key Metrics
Key financial metrics for RANI
Metric
Value
Price
$1.09
Market Cap
$97.14M
P/E Ratio
-3.78
EPS
$-0.29
Dividend Yield
0.00%
52-Week High
$3.87
52-Week Low
$0.39
Volume
20.48K
Avg Volume
0
Revenue (TTM)
$3.17M
Net Income
$-36.23M
Gross Margin
0.00%
Top Hedge Funds Holding RANI
Farallon Capital holds 78.00K shares of RANI, changed +0.00% as of Mar 31, 2026.
Hedge funds tracked by Rallies that own RANI include Farallon Capital. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Rani Therapeutics Holdings, Inc. Class A Common Stock.
Does Rallies show 13F holders for RANI?
Yes. Rallies tracks hedge fund and 13F ownership data for RANI, including fund names, share counts, latest tracked quarter, and position changes when available.
Is RANI research on Rallies investment advice?
No. Rallies provides research, data, and educational context for RANI. It does not provide personalized investment advice.